Baseline Epigenetics as a Biomarker of Mepolizumab Response in Severe Asthma
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Authors
- Ramesh Kurukulaaratchy (ORCID: https://orcid.org/0000-0002-1588-2400)
- Syed Hasan Arshad (ORCID: https://orcid.org/0000-0001-5988-235X)
- Hongmei Zhang (ORCID: https://orcid.org/0000-0003-3557-0364)
- Xin Jin (ORCID: https://orcid.org/0009-0001-6018-4871)
Institutions
- University of Tennessee Health Science Center (US)
- St Mary's Hospital (GB)
- David Hide Asthma and Allergy Research Centre (GB)
- St. Mary's Hospital (GB)
- University of Southampton (GB)
- University of Memphis (US)
Publication Details
- Journal
- Clinical & Experimental Allergy
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1111/cea.70195
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00